Centers for Disease Control 

National Institute for Occupational Safety and Health 

Advisory Board on Radiation and Worker Health (ABRWH) 

145th Meeting

Wednesday, April 27, and Thursday April 28, 2022 

Wednesday, April 27, 2022 

Summary Proceedings

The Advisory Board on Radiation and Worker Health meeting convened via teleconference at 1:00 p.m.

Eastern Daylight Time (EDT), Dr. Henry A. Anderson, Chair, presiding.

Attendees

Members

Henry A. Anderson, Chair

Josie Beach, Member

Bradley P. Clawson, Member

R. William Field, Member

David Kotelchuck, Member

James E. Lockey, Member

David B. Richardson, Member

Genevieve S. Roessler, Member

Phillip Schofield, Member

Loretta R. Valerio, Member

Paul L. Ziemer, Member

Rashaun Roberts, Designated Federal Official

Non-Members, Registered and/or Public Comment Participants:

Adams, Nancy, NIOSH Contractor

Barrie, Terrie

Barton, Bob, SC&A

Behling, Kathy, SC&A

Black, Finn, SC&A

Blaze, D'lanie

Buchanan, Ron, SC&A

Burgan, Arthur

Burgos, Zaida, NIOSH

Calhoun, Grady, DCAS

Cook, Madeline, DCAS

Crawford, Chris, DOL

DeGarmo, Denise
2 

Dressman, Kevin, DOE

Fitzgerald, Joe, SC&A

Gheen, Angelica, DCAS

Gogliotti, Rose, SC&A

Griego, Regina, DOE

Hand, Donna

Lewis, Greg, DOE

McCloskey, Pat, ORAU Team

Mcgolerick, Robert, HHS

Nelson, Chuck, DCAS

Rafky, Michael, HHS

Rutherford, LaVon, DCAS

Taulbee, Tim, DCAS

Roll Call/Welcome - Dr. Rashaun Roberts, DFO

Dr. Rashaun Roberts called to order the Advisory Board on Radiation and Worker Health at 1:00 pm EDT 

on April 27, 2022, via teleconference. A roll call of all ABRWH members confirmed that a quorum was 

present. The quorum was maintained throughout the meeting. Board Members announced any conflicts 

during roll call. Dr. Roberts turned the meeting over to Dr. Anderson, Board Chair. 

Program Updates: NIOSH, DOL, and DOE

Grady Calhoun (NIOSH), Chris Crawford (DOL), and Greg Lewis (DOE) gave updates of each 

organization’s activities for the EEOICPA Program and responded to questions from Board Members. Kevin 

Dressman introduced himself as the new Director of DOE’s Office of Health and Safety, replacing Pat 

Worthington, who retired.

Procedures Review Finalization/Document Approvals – Josie Beach, 

Chair of Subcommittee for Procedures Review

After introductory remarks Ms. Beach called on Kathy Behling, SC&A to describe the Subcommittee’s 

completed review of seven documents. Those documents are:

• ORAUT-OTIB-0066, rev. 01, “Calculation of Dose from Intakes of Special Tritium Compounds” 

• ORAUT-RPRT-0086, rev. 00, “Internal Dosimetry Coworker Data Completeness Test”

• DCAS-PER-057, rev. 0, “General Steel Industries”

• DCAS-PER-080, rev. 0, “General Steel Industries”

• DCAS-PER-063, rev. 0, “Aluminum Company of America – Pennsylvania (ALCOA-PN)”

• DCAS-PER-065, rev. 0., “Anaconda”

• DCAS-PER-064, rev. 0, “DuPont Deep Water Works”

After Ms. Behling presented the Subcommittee’s work on each document, the Board voted to close the 

reviews of all seven documents.
3 

Update on Review of SEC-00253 Reduction Pilot Plant, Huntington, 

WV: June 7, 1976 – November 26, 1978 – Dr. Henry Anderson, Chair of 

Uranium Refining Atomic Weapons Employer (URAWE) Work Group

After introductory remarks, Dr. Anderson called on Dr. Ron Buchanan, SC&A, to describe the Work Group’s 

work on SEC Petition SEC-00253. Dr. Buchanan presented information about the Reduction Pilot Plant’s 

(RPP) operations, and the technical documents that DCAS and ORAU Team have prepared for the site. 

He then presented information from DCAS’s Evaluation Report for Petition SEC-00253, and SC&A’s review 

of that Evaluation Report. The class that DCAS evaluated for this petition was all International Nickel 

Company security personnel who worked at any location within the RPP facility during the period of June 

7, 1976, to November 26, 1978. SC&A developed two observations during their review of the SEC 

Evaluation Report concerning the magnitude of the doses that should be reconstructed for members of the 

class. However, they did not find any reason to conclude that dose reconstruction was not feasible.

Following Dr. Buchanan’s presentation, the Board voted to accept the conclusion in DCAS’s Evaluation 

Report. The Board approved a draft letter to the Secretary, HHS, agreeing that dose reconstruction was 

feasible, and an SEC class was not warranted.

Public Comment

Members of the public provided comments related to the Pinellas Plant, and the SEC status of Portsmouth, 

Oak Ridge, and Paducah Gaseous Diffusion Plants. After public comment Dr. Anderson adjourned the 

meeting at 5:19 p.m. 
4 

Thursday, April 28, 2022 

Summary Proceedings

The Advisory Board on Radiation and Worker Health meeting convened via teleconference at 1:01 p.m.

Eastern Daylight Time (EDT), Dr. Henry Anderson, Chair, presiding.

Attendees

Members

Henry A. Anderson, Chair

Josie Beach, Member

Bradley P. Clawson, Member

R. William Field, Member

David Kotelchuck, Member

James E. Lockey, Member

David B. Richardson, Member

Genevieve S. Roessler, Member

Phillip Schofield, Member

Loretta R. Valerio, Member

Paul L. Ziemer, Member

Rashaun Roberts, Designated Federal Official

Non-Members, Registered and/or Public Comment Participants:

Adams, Nancy, NIOSH Contractor 

Barrie, Terrie, ANWAG 

Barton, Bob, SC&A 

Buchanan, Ron, SC&A 

Burgos, Zaida, NIOSH 

Calhoun, Grady, DCAS 

Cardarelli, John, DCAS 

Fester, Joshua, On behalf of Petitioner 

Fitzgerald, Joe, SC&A 

Gogliotti, Rose, SC&A 

Lewis, Greg, DOE 

Naylor, Jenny, HHS OGC 

Nelson, Charles, DCAS 

Rutherford, Lavon, DCAS 

Sisko, Jeannie 

Taulbee, Tim, DCAS

Roll Call/Welcome – Dr. Rashaun Roberts, DFO

Dr. Rashaun Roberts called to order the Advisory Board on Radiation and Worker Health at 1:01 pm EST. 

A roll call of all ABRWH members confirmed that a quorum was present. The quorum was maintained 

throughout the meeting. Dr. Roberts noted the agenda includes a discussion of SEC-00188 for Sandia 
5 

national Lab, and that Loretta Valerio has a conflict for that site. Ms. Valerio will leave the meeting during 

that discussion.

SEC Petition Status Update & SEC Qualification Process – Chuck 

Nelson, DCAS

Mr. Nelson reported that DCAS is in the process of preparing an addendum to the evaluation report for

petition SEC-0221 for Lawrence Livermore National Lab for the years 1990 to 1995. Travel for data capture 

will resume soon, and DCAS is coordinating with Lawrence Livermore to schedule visits. DCAS and SC&A 

are continuing work on SEC petitions from Hanford, Savannah River, Sandia National Lab, Los Alamos 

National Lab, Idaho National Lab, Argonne National Lab-West, Area IV Santa Susanna, Metals & Controls, 

DeSoto Avenue Facility, the Y-12 Plant, and the Pinellas Plant. The Uranium Refining AWE Work Group 

reported the results of its review of Reduction Pilot Plant at yesterday’s session. DCAS continues to 

evaluate records for West Valley Demonstration Project to decide if an 83.14 petition is warranted for the 

years 1966-1968. 

Update on Review of SEC-00188 Sandia Petition Addendum 2; Jan. 1, 

1997 – May 21, 2011 – Dr. Henry Anderson, Chair, Sandia Workgroup

Mr. Chuck Nelson, DCAS presented the history of SEC-00188. The petition was for security personnel who 

worked in any area of Sandia National Lab for the period January 1, 1963, through May 21, 2011. DCAS’s 

initial evaluation of the petition concluded that internal dose reconstruction was not feasible for any Sandia 

employee from January 1, 1949, through December 31, 1994, and a class has been added to the SEC for 

that period. Subsequently, DCAS concluded that internal dose also could not be reconstructed for the period 

January 1, 1995, through December 31, 1996, and that class has been added to the SEC. 

Mr. Nelson then described DCAS’s Addendum 2 to the Evaluation Report that addresses the period January 

1, 1997, through May 21, 2011. DCAS’s conclusion is that doses can be reconstructed for all employees at 

Sandia for this period because the personal air sampling program illustrated that employees who were not 

on a bioassay program did not exceed 100 mrem Committed Effective Dose Equivalent in a year.

Next, Joe Fitzgerald, SC&A, described SC&A’s review of Addendum 2 to the Evaluation Report. Since 

earlier DCAS work on SEC-00188 had resulted in the addition of SEC classes, SC&A did not review those 

efforts. Consequently, their current effort included some review of years before 1997 at Sandia in order to 

gain a good understanding of the site.

Bob Barton, SC&A, presented the results of SC&A’s review of Addendum 2. The review focused on the 

personal air sampling program because DCAS’s conclusion is largely based on that program. SC&A 

carefully reviewed whether the available personal air sampler data were sufficient to support DCAS’s 

conclusion. Despite the fact that it’s impossible to know how much personal air sampler data is not available, 

it appears that the available data tends to represent more highly exposed workers. Thus, the available 

personal air sampler data supports a bounding dose estimate for the applicable workers. SC&A agreed 

with DCAS’s conclusion that doses can be reconstructed for the period under consideration. They did, 

however, question whether current dose reconstruction techniques were adequate in two situations. DCAS 

is working on resolving these. SC&A and DCAS agree that these issues will not make dose reconstruction 

infeasible, and so are Site Profile issues, not SEC issues.

At its last meeting the Sandia Workgroup had voted to accept DCAS’s conclusion that doses could be 

reconstructed for the period under consideration, so that was brought as a motion to the full Board. After 

some discussion, the Board voted to table that motion, so no action was taken on Addendum 2.
6 

Subcommittee on Dose Reconstruction Reviews Update & Discussion

– Dr. David Kotelchuck, Chair, Subcommittee on Dose Reconstruction 

Reviews

Dr. Kotelchuck presented the results of SC&A’s evaluation of the Subcommittee’s case selection process. 

Based on SC&A’s report the Subcommittee has decided to emphasize certain criteria during case selection. 

The Subcommittee will broaden the Probability of Causation range, and will pay attention to year of first 

employment, employment duration, gender, age of completed dose reconstruction, and certain 

underrepresented sites.

Board Work Session

Dr. Anderson reported that there has been no word about the slate of potential additional Board members

that was submitted some time ago. He also reported that the Board’s charter was recently renewed, with a 

new expiration date of September 30, 2023.

The Board discussed public comments from the previous meeting, and Workgroup Chairs reported on

recent activities and future plans. Board members discussed difficulties they are having with expiring Smart 

Cards and Certificates. The pandemic and Cybersecurity Upgrade Initiative have resulted in some problems 

getting access as desired.

Dr. Roberts reminded attendees of scheduled future meetings: conference call June 15 at 11:00; full 

meeting August 17 and 18; teleconference October 20; and full meeting December 7 and 8. The Board is 

hopeful that the August meeting will be in-person near Idaho National Lab, and the December meeting will 

be near the former Pinellas site. The Board scheduled a teleconference meeting for February 15, 2023, 

and a full meeting for April 19 and 20, 2023.

Meeting Adjourned

The meeting was adjourned at 4:30 pm EDT.